SCHEMBL623631

SCHEMBL623631

CC(C)(C)c1ccc(O)c(N=Cc2ccccc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
POLB P06746 1/20 0.63
MAPT P10636 7/20 0.59
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 5/20 0.59
PKM P14618 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.47
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
HPGD P15428 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP2D6 P10635 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
LIG1 P18858 1/20 0.42
RECQL P46063 1/20 0.42
HTT P42858 3/20 0.41
ESRRG P62508 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30373545 1.00 GAA (0.63) GAAMEN1KMT2APOLBMAPT
SCHEMBL623630 1.00 GAA (0.63) GAAMEN1KMT2APOLBMAPT
SCHEMBL15317953 0.85 MAPT (0.54) GAAMEN1KMT2APOLBMAPT
SCHEMBL22103729 0.85 GAA (0.72) GAAMEN1KMT2APOLBMAPT
SCHEMBL15315387 0.81 KMT2A (0.50) GAAMEN1KMT2APOLBMAPT
SCHEMBL18688530 0.80 KMT2A (0.49) GAAMEN1KMT2APOLBMAPT
SCHEMBL29354566 0.79 GAA (0.53) GAAMEN1KMT2APOLBMAPT
SCHEMBL623370 0.79 GAA (0.53) GAAMEN1KMT2APOLBMAPT
SCHEMBL623371 0.79 GAA (0.53) GAAMEN1KMT2APOLBMAPT
SCHEMBL14337265 0.79 PTGS2 (0.47) GAAMEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-17 US claimed
WO-2012021707-A2 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-16 WO claimed
EP-3638647-B1 PROCESS FOR MONO N-ALKYLATION OF AMINOPHENOL SABIC GLOBAL TECHNOLOGIES BV (NL) 2024-01-17 EP disclosed
CN-110740987-B Method for mono-N-alkylation of aminophenols SABIC环球技术有限责任公司 2023-04-21 CN disclosed
US-11066354-B2 Process for mono N-alkylation of aminophenol SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2021-07-20 US disclosed
US-20200140373-A1 PROCESS FOR MONO N-ALKYLATION OF AMINOPHENOL SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-05-07 US disclosed
EP-3638647-A1 PROCESS FOR MONO N-ALKYLATION OF AMINOPHENOL SABIC Global Technologies B.V. (NL) 2020-04-22 EP disclosed
CN-110740987-A Process for mono-N-alkylation of aminophenols SABIC环球技术有限责任公司 2020-01-31 CN disclosed
WO-2018228981-A1 PROCESS FOR MONO N-ALKYLATION OF AMINOPHENOL SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS UPF1, NUDT21, RNGTT GAA 2293/4885MEN1 3033/4885KMT2A 1956/4885
US-11066354-B2 Process for mono N-alkylation of aminophenol CYP4A11, CYP4B1, TYR GAA 2261/4885MEN1 2612/4885KMT2A 1118/4885
US-20200140373-A1 PROCESS FOR MONO N-ALKYLATION OF AMINOPHENOL CYP4A11, CYP4B1, TYR GAA 2261/4885MEN1 2612/4885KMT2A 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.